NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

The SAP was submitted to all four regulators prior to trial unblinding. The SAP contained the trial design. It has not been rejected by regulators. The successful trial was not confounded. TLD at NYAS made that clear:

https://virtualtrials.org/dcvax

Our p values 0.001 and 0.002 are super statistically significant, meaning the outcomes in the trial are expected hold for the GBM population writ large, while our hazard ratios show the results were not due to chance.

0.05 is the minimum p value for approval. 0.001 orders of magnitude better.

Companies are required by the SEC to list possible risks in their annual 10-K filings.

The successful trial shows those possible risks are not valid.

Nothing you state here or on any of the platforms you post has any factual basis in reality.